Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jacob, Passweg"'
Autor:
Dietger Niederwieser, Dirk Hasenclever, Wolfgang Berdel, Bart J. Biemond, Haifa Al-Ali, Yves Chalandon, Michel van Gelder, Christian Junghanß, Gösta Gahrton, Mathias Hänel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jacob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Leo F. Verdonck, Vladan Vucinic, Bob Löwenberg, Jan Cornelissen
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Given the selection of elderly patients with AML in first complete remission (CR1) the advantage of consolidation with allogeneic hematopoietic cell transplantation (HCT) over chemotherapy is still unclear. Newly diagnosed AML patients in CR1 aged
Externí odkaz:
https://doaj.org/article/e24e854d3915489f8bfdf3f02374efc6
Autor:
Helena Simeunovic, Martina Dickenmann, Mitja Nabergoj, Helen Baldomero, Stavroula Masouridi‐Levrat, Gayathri Nair, Urs Schanz, Jacob Passweg, Alicia Rovo, Yves Chalandon, Ekaterina Rebmann
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 262-265 (2023)
Abstract Despite the high cure rate with initial therapy, approximately 10% of Hodgkin lymphoma (HL) patients are refractory to initial treatment, and up to 30% of patients will relapse after achieving initial complete remission. Despite promising in
Externí odkaz:
https://doaj.org/article/ca34f888599049ba8011b94a18ef2ad3
Autor:
Robert A. Brodsky, Jacob Passweg, Panagiotis Tsirigotis, Emmanuel Nikolousis, Ioannis Batsis, Maria Tsagiopoulou, Ioannis Baltadakis, Kostas Stamatopoulos, Pat Taylor, Tasoula Touloumenidou, Achilles Anagnostopoulos, Dimitrios A. Tsakiris, Apostolia Papalexandri, Eleni Gavriilaki, Andreas Holbro, Nikolaos Charchalakis, Despina Mallouri, Ioanna Sakellari, Maria Liga, Maria Stamouli, Alexandros Spyridonidis, Fotis Psomopoulos, Evangelia Yannaki, Maria Koutra
Publikováno v:
Thrombosis and Haemostasis. 120:638-646
Transplant-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication of allogeneic hematopoietic cell transplantation (HCT). We hypothesized that pretransplant genetic susceptibility is evident in adult TA-TMA and further inve
Autor:
Helena Simeunovic, Martina Dickenmann, Mitja Nabergoj, Helen Baldomero, Stavroula Masouridi‐Levrat, Gayathri Nair, Urs Schanz, Jacob Passweg, Alicia Rovo, Yves Chalandon, Ekaterina Rebmann
Publikováno v:
Simeunovic, Helena; Dickenmann, Martina; Nabergoj, Mitja; Baldomero, Helen; Masouridi-Levrat, Stavroula; Nair, Gayathri; Schanz, Urs; Passweg, Jacob; Rovo, Alicia; Chalandon, Yves; Rebmann, Ekaterina (2022). Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020. eJHaem, 4(1), pp. 262-265. Wiley 10.1002/jha2.629
Despite the high cure rate with initial therapy, approximately 10% of Hodgkin lymphoma (HL) patients are refractory to initial treatment, and up to 30% of patients will relapse after achieving initial complete remission. Despite promising initial res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a12ec50566d1a8a0d6e2cd6f8053c5
Autor:
Effie W Petersdorf, Mary Carrington, Colm O'hUigin, Mats Bengtsson, Dianne De Santis, Valerie Dubois, Ted Gooley, Mary Horowitz, Katharine Hsu, J Alejandro Madrigal, Martin J Maiers, Mari Malkki, Caroline McKallor, Yasuo Morishima, Machteld Oudshoorn, Stephen R Spellman, Jean Villard, Phil Stevenson, Martin Maiers, Stephen Spellman, Jane Apperley, Peter Bardy, Ghislaine Bernard, Yves Bertrand, Adrian Bloor, Chiara Bonini, Stephane Buhler, Laura Bungener, Helen Campbell, Kristina Carlson, Ben Carpenter, Anne Cesbron, Christian Chabannon, Yves Chalandon, Jeremy Chapman, Réda Chebel, Patrice Chevallier, Gerda Choi, Matt Collin, Jan J Cornelissen, Charles Crawley, Lloyd D'Orsogna, Jean-Hugues Dalle, Eric Deconinck, Muriel DeMatteis, Mary Diviney, Anne Dormoy, Katia Gagne, Brenda Gibson, Maria Gilleece, David Gottlieb, John Gribben, Tayfun Güngör, Mike Haagenson, Cathie Hart, Rhonda Holdsworth, Ian Humphreys, Yoshihisa Kodera, Mickey Koh, Hélène Labussière-Wallet, Arjan C Lankester, Neubery Lardy, Sarah Lawson, Xavier Leleu, Stephen MacKinnon, Ram Malladi, Steven GE Marsh, Murray Martin, Neema P Mayor, I Grant McQuaker, Ellen Meijer, Satoko Morishima, Emmanouil Nikolousis, Kim Orchard, Jacob Passweg, Amit Patel, Katherine Patrick, Béatrice Pedron, Andy Peniket, Julia Perry, Eefke Petersen, Victoria Potter, Mike Potter, Rachel Protheroe, Nicole Raus, Carmen Ruiz de Elvira, Nigel Russell, Nicholaas PM Schaap, Urs Schanz, Harry Schouten, Roderick Skinner, John Snowden, Eric Spierings, Colin Steward, Eleni Tholouli, Alycia Thornton, Marcel Tilanus, Arnold van de Meer, Hendrik Veelkens, Paul Veys, Narelle Watson, Lyanne Weston, Keith Wilson, Marie Wilson, Robert Wynn, József Zsiros
Publikováno v:
The Lancet Haematology
The Lancet Haematology, Elsevier, 2021, 7 (1), pp.e50-e60. ⟨10.1016/s2352-3026(19)30208-x⟩
Petersdorf, E W, Carrington, M, O'hUigin, C, Bengtsson, M, De Santis, D, Dubois, V, Gooley, T, Horowitz, M, Hsu, K, Madrigal, J A, Maiers, M J, Malkki, M, McKallor, C, Morishima, Y, Oudshoorn, M, Spellman, S R, Villard, J, Stevenson, P & International Histocompatibility Working Group in Hematopoietic Cell Transplantation 2020, ' Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation : a retrospective cohort study ', The Lancet Haematology, vol. 7, no. 1, pp. e50-e60 . https://doi.org/10.1016/S2352-3026(19)30208-X
The Lancet Haematology, 7(1), e50-e60. Lancet Publishing Group
The Lancet. Haematology, Vol. 7, No 1 (2020) pp. e50-e60
The Lancet Haematology, 7(1), E50-E60. ELSEVIER SCI LTD
The Lancet Haematology, 7(1), e50. Lancet Publishing Group
Lancet Haematol
The Lancet Haematology, Elsevier, 2021, 7 (1), pp.e50-e60. ⟨10.1016/s2352-3026(19)30208-x⟩
Petersdorf, E W, Carrington, M, O'hUigin, C, Bengtsson, M, De Santis, D, Dubois, V, Gooley, T, Horowitz, M, Hsu, K, Madrigal, J A, Maiers, M J, Malkki, M, McKallor, C, Morishima, Y, Oudshoorn, M, Spellman, S R, Villard, J, Stevenson, P & International Histocompatibility Working Group in Hematopoietic Cell Transplantation 2020, ' Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation : a retrospective cohort study ', The Lancet Haematology, vol. 7, no. 1, pp. e50-e60 . https://doi.org/10.1016/S2352-3026(19)30208-X
The Lancet Haematology, 7(1), e50-e60. Lancet Publishing Group
The Lancet. Haematology, Vol. 7, No 1 (2020) pp. e50-e60
The Lancet Haematology, 7(1), E50-E60. ELSEVIER SCI LTD
The Lancet Haematology, 7(1), e50. Lancet Publishing Group
Lancet Haematol
Background: The success of unrelated haemopoietic cell transplantation (HCT) is limited by graft-versus-host disease (GVHD), which is the main post-transplantation challenge when HLA-matched donors are unavailable. A sequence dimorphism in exon 1 of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::195a18e65915d7d3471d1ddf38d8b61a
https://www.hal.inserm.fr/inserm-03349714/document
https://www.hal.inserm.fr/inserm-03349714/document
Autor:
Michael Potter, Meral Beksac, Patrick Hayden, Uwe Platzbecker, Stephanie Nguyen-Quoc, Linda Koster, William Arcese, Alida Dominietto, Nicolaas Schaap, Monique C. Minnema, Edouard Forcade, Dirk Jan Eikema, Johanna Tischer, Virginie Gandemer, Ibrahim Yakoub-Agha, Hermann Einsele, Nicolaus Kröger, Angelo Michele Carella, Liesbeth C. de Wreede, Fabio Ciceri, Per Ljungman, Joan Hendrik Veelken, Jacob Passweg, Laure Vincent, Arancha Bermúdez, Adrian Bloor, Stefan Schönland, Attilio Olivieri
Publikováno v:
Bone Marrow Transplantation, 56, 2367-2381
Bone Marrow Transplantation, 56, 10, pp. 2367-2381
Bone Marrow Transplantation, 56(10), 2367-2381. SPRINGERNATURE
Bone Marrow Transplantation
Bone Marrow Transplantation, 56, 10, pp. 2367-2381
Bone Marrow Transplantation, 56(10), 2367-2381. SPRINGERNATURE
Bone Marrow Transplantation
The EBMT Chronic Malignancies Working Party performed a retrospective analysis of 215 patients who underwent a second allo-HCT for myeloma between 1994 and 2017, 159 for relapse and 56 for graft failure. In the relapse group, overall survival (OS) wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576c8e78782023de844351453f89f092
http://hdl.handle.net/2066/244085
http://hdl.handle.net/2066/244085
Autor:
Anna Sureda, Carme Canals, Reyes Arranz, Dolores Caballero, Josep Maria Ribera, Mats Brune, Jacob Passweg, Rodrigo Martino, David Valcárcel, Joan Besalduch, Rafael Duarte, Angel León, Maria Jesus Pascual, Ana García-Noblejas, Lucia López Corral, Bianca Xicoy, Jordi Sierra, Norbert Schmitz
Publikováno v:
Haematologica, Vol 97, Iss 2 (2012)
Background Although Hodgkin’s lymphoma is a highly curable disease with modern chemotherapy protocols, some patients are primary refractory or relapse after first-line chemotherapy or even after high-dose therapy and autologous stem cell transplant
Externí odkaz:
https://doaj.org/article/4fd3253312394fac96531a3fddba8756
Autor:
Parvez Ahmed, Asma El Quessar, Nicolas Novitzky, East-Mediterranean (Embmt), Fazal Hussain, Mary M. Horowitz, Juliana Martinez Rolon, Lamia Torjemane, M. Mohty, Jeff Szer, African (AfBMT) Blood, Omar Fahmy, Marcelo C. Pasquini, Marrow Transplantation, Ardeshir Ghavamzadeh, Amr Nassar, Rose-Marie Hamladji, Yoshihisa Kodera, Alaa Elhaddad, Gregorio Jaimovich, Nosa Bazuaye, Miguel R. Abboud, Murtadha Al Khabori, Abdelghani Tbakhi, Nour Ben Abdejalil, Lahoucine Mahmal, Mohamed Amine Bekadja, Mickey Koh, Hassan El-Solh, Marrow Transplantation Groups, Alois Gratwohl, Salman Naseem Adil, Shahrukh K. Hashmi, Daniel J. Weisdorf, Hani Alhashmi, Mohammed Al Huneini, Mahmoud Sarhan, Mahmoud Aljurf, Helen Baldomero, Syed Ziauddin A. Zaidi, Mani Ramzi, Kristjan Paulson, Nicolaus Kröger, Jacob Passweg, Amir Ali Hamidieh, Amal Al-Seraihy, Hildegard Greinix, José R. Nuñez, Ahmed Ibrahim, Dietger Niederwieser
Publikováno v:
Bone Marrow Transplantation. 54:402-417
Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006-2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.8
Autor:
Andrea Bacigalupo, Gerard Socie’, Edoardo Lanino, Arcangelo Prete, Franco Locatelli, Anna Locasciulli, Simone Cesaro, Avichai Shimoni, Judith Marsh, Mats Brune, Maria Teresa Van Lint, Rosi Oneto, Jacob Passweg, for the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation, (SAA WP-EBMT)
Publikováno v:
Haematologica, Vol 95, Iss 6 (2010)
Background We analyzed the outcome of 100 patients with acquired severe aplastic anemia undergoing an alternative donor transplant, after immune suppressive therapy had failed.Design and Methods As a conditioning regimen, patients received either a c
Externí odkaz:
https://doaj.org/article/1b97b52180a94afd8d7ef8951d2c4c52
Autor:
Gérard Socié, Péter Reményi, Ardeshir Ghavamzadeh, Mohamad Mohty, Sebastian Giebel, Arnon Nagler, Patrice Chevallier, Myriam Labopin, Per Ljungman, Maija Itälä-Remes, Jacob Passweg, Montserrat Rovira, Nathalie Fegueux, Alessandro Rambaldi, Tomasz Czerw, Xavier Poiré, Boris Anafasyev, Didier Blaise, Martin Bornhäuser
Publikováno v:
European journal of cancer (Oxford, England : 1990), Vol. 106, p. 212-219 (2019)
BACKGROUND: Brivanib is a selective inhibitor of vascular endothelial growth factor and fibroblast growth factor (FGF) signalling. We performed a phase II randomised discontinuation trial of brivanib in 7 tumour types (soft-tissue sarcomas [STS], ova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ffa19ba3b5fb7b538c20371fea73472
https://hdl.handle.net/2078.1/237857
https://hdl.handle.net/2078.1/237857